PFD report

Carly Marie GORDON · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 4 Aug 2017•Exeter and Greater Devon

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
2

Raised in this report

Recipients
5

Named on the report

Responses found
4

Of 5 recipients

Stated actions
16

Described in responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised2

  1. Failure to review patients receiving extended-term medication for suitability of continued long-term use
    Part of recurring concern: Inadequate review of long-term medication use
  2. Failure to prescribe longer-acting rather than shorter-acting benzodiazepines for long-term use
    Part of recurring concern: Unsafe medication prescribing
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.7

  1. Action

    Remind practices through the regular electronic newsletter to review patients receiving short-acting benzodiazepines.

    Stated by Devon LMCStated plannedThe respondent said that this action was planned when they made their response on 3 December 2017.
  2. Action

    Make the relevant short-acting benzodiazepine review information available on the Devon LMC website.

    Stated by Devon LMCStated plannedThe respondent said that this action was planned when they made their response on 3 December 2017.
  3. Action

    Request national mental health leads to write to all mental health trust medical directors and chief pharmacists, raising benzodiazepine prescribing and withdrawal risks and disseminating relevant guidance.

    Stated by NHS EnglandStated plannedThe respondent said that this action was planned when they made their response on 3 December 2017.

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.2

  1. Position

    BAP guidance does not require universal substitution of shorter-acting benzodiazepines; prescribing choice and duration depend on individual clinical judgment.

    Stated by NHS EnglandDisputes the concernThe respondent disagreed with part of the concern or the basis for it.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to review patients receiving extended-term medication for suitability of continued long-term use

Wider context from the report

“(2) All patients who receive this drug for an extended period of time should be reviewed by their medical advisors to reassess their suitability for the long term use of this particular medication. ”

Is this part of a recurring concern?

Yes — Inadequate review of long-term medication use.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to prescribe longer-acting rather than shorter-acting benzodiazepines for long-term use

Wider context from the report

“(1) The long term use of shorter acting Benzodiazepine instead of longer acting Benzodiazepine in accordance with the British Association of Psychopharmacology Guidelines should be followed when patients are prescribed this drug to avoid dependence. ”

Is this part of a recurring concern?

Yes — Unsafe medication prescribing.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Remind practices through the regular electronic newsletter to review patients receiving short-acting benzodiazepines.

Verbatim wording from the response

“Devon LMC is dedicated to maintaining high standards of care and professionalism and is very happy to help disseminate important information in an appropriate manner to our members and constituent practices. I can confirm the LMC, via our regular electronic newsletter, will remind practices regarding review of patients receiving short acting Benzodiazepines.”

Source location

2017-0320-Response-by-Devon-LMC_Redacted
Page 1 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Make the relevant short-acting benzodiazepine review information available on the Devon LMC website.

Verbatim wording from the response

“In addition, we will ensure the information is made available on our website. Please could I ask you to provide a link to the relevant documentation?”

Source location

2017-0320-Response-by-Devon-LMC_Redacted
Page 1 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Request national mental health leads to write to all mental health trust medical directors and chief pharmacists, raising benzodiazepine prescribing and withdrawal risks and disseminating relevant guidance.

Verbatim wording from the response

“It is important that prescribers and pharmacists are aware of the risks associated with the use of benzodiazepines when prescribing or dispensing these medicines. In response to the specific concerns raised in your letter, I will ask ████████ ████████ our National Clinical Director for mental health, and ████████ our Head of Mental Health and LD Medicines Strategy to write to all medical directors and chief pharmacists in mental health trusts in England to:”

Source location

2017-0320-Response-by-NHS-England
Page 2 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Audit patients prescribed Lorazepam and all practice patients receiving it on repeat prescription.

Verbatim wording from the response

“In regard to my own personal prescribing I have audited every patient I have prescribed Lorazepam to between 27/05/2016 and 13/09/2017.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 3 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Send personal letters asking patients with repeat benzodiazepine prescriptions to arrange targeted medication reviews.

Verbatim wording from the response

“Reviewing medication is regular practice at our surgery. However we have now considered a structured systemic approach for patients on Benzodiazepines to those reviews following our own significant event discussion of this case and the regulation 28 report.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 4 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Remind prescribing staff to discuss short-term benzodiazepine use, conduct regular reviews, and avoid adding these medicines to repeat prescriptions.

Verbatim wording from the response

“For those thought requiring acute prescriptions we have reminded prescribing staff of the requirement to discuss with patients about the short term use of Benzodiazepines and regular reviews of both symptoms and prescriptions; also, not to add these medications to repeat prescriptions. I hope my own personal audit evidences that.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 4 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Change future prescribing practice regarding switching short-acting benzodiazepines to longer-acting alternatives.

Verbatim wording from the response

“• “Switching from a short half-life Benzodiazepine to a long half-life Benzodiazepine before gradual taper should be reserved for patients having problematic withdrawal symptoms”.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 2 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

BAP guidance does not require universal substitution of shorter-acting benzodiazepines; prescribing choice and duration depend on individual clinical judgment.

Verbatim wording from the response

“1) The long term use of shorter acting benzodiazepine instead of longer acting benzodiazepine in accordance with the British Association of Psychopharmacology guidelines should be followed when patients are prescribed this drug to avoid dependence; and”

Source location

2017-0320-Response-by-NHS-England
Page 1 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Switching to a long-acting benzodiazepine was not considered warranted in this case because clinical indications outweighed the risks.

Verbatim wording from the response

“• “Switching from a short half-life Benzodiazepine to a long half-life Benzodiazepine before gradual taper should be reserved for patients having problematic withdrawal symptoms”.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 2 · response
Published 3 December 2017

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.9

  1. 1

    Refer prescribing performance for external appraisal, revalidation and performance review.

    Stated by Fremington Medical CentreStated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
  2. 2

    Stop adding or continuing repeat benzodiazepine prescriptions for newly registering patients not already receiving them on repeat.

    Stated by Fremington Medical CentreStated plannedThe respondent said that this action was planned when they made their response on 3 December 2017.
  3. 3

    Review and reflect on current benzodiazepine prescribing guidance.

    Stated by Fremington Medical CentreStated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
  4. 4

    Discuss the case and prescribing reflection with the appraiser.

    Stated by Fremington Medical CentreStated plannedThe respondent said that this action was planned when they made their response on 3 December 2017.
  5. 5

    Provide a free-access e-learning programme supporting better medication prescribing.

    Stated by Royal College of General PractitionersStated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
  6. 6

    Include safe prescribing and medicines management in the GP curriculum and associated training.

    Stated by Royal College of General PractitionersStated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
  7. 7

    Examine safe prescribing and medicines management routinely in the Membership Examination.

    Stated by Royal College of General PractitionersStated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
  8. 8

    Provide guidance on benzodiazepine and other medication use, including safe withdrawal support and the 2013 consensus statement.

    Stated by Royal College of General PractitionersStated completedThe respondent said that this action was complete when they made their response on 3 December 2017.
  9. 9

    Support the RCGP certificate in the management of drug misuse.

    Stated by Royal College of General PractitionersStated completedThe respondent said that this action was complete when they made their response on 3 December 2017.

Recipient positions A position is what a recipient says about a concern when they do not describe a specific action.1

  1. 1

    Commenting on an individual GP’s performance is outside the College’s remit.

    Stated by Royal College of General PractitionersOutside remitThe respondent said that this matter was outside its role or authority.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Refer prescribing performance for external appraisal, revalidation and performance review.

Verbatim wording from the response

“• I have referred myself voluntarily to the Deputy Medical Director/RO Appraisal, Revalidation, Performance Lead NHS England Devon, Cornwall, Isles of Scilly Area Team, ████████ This is in order for her to review my performance in the management of Carly Gordon.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 4 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Stop adding or continuing repeat benzodiazepine prescriptions for newly registering patients not already receiving them on repeat.

Verbatim wording from the response

“We have made a commitment not to add (or continue repeat prescriptions from patients registering from other practices) Benzodiazepines to a repeat prescription if not already on repeat.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 4 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Review and reflect on current benzodiazepine prescribing guidance.

Verbatim wording from the response

“I have read thoroughly both:”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 1 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Discuss the case and prescribing reflection with the appraiser.

Verbatim wording from the response

“• I have significantly reflected on this case and will discuss this with my appraiser.”

Source location

2017-0320-Response-by-Fremington-Medical-Centre
Page 4 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Provide a free-access e-learning programme supporting better medication prescribing.

Verbatim wording from the response

“In addition to my comments above, the RCGP supports a range of other educational initiatives which support the better prescribing of medication and thus the improved care of patients – these include the RCGP certificate in the management of drug misuse and also a free to access e learning programme.”

Source location

2017-0320-Response-by-RCGP
Page 2 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Include safe prescribing and medicines management in the GP curriculum and associated training.

Verbatim wording from the response

“RCGP curriculum currently contains safe prescribing and medicines management approaches and this is examined routinely as part of the Membership Examination which all doctors take should they wish to be accredited as a general practitioner. Details of the curriculum can be found at http://www.rcgp.org.uk/training-exams/gp-curriculum-overview/online-curriculum/managing-complex-care/3-14-drugs-and-alcohol-misuse.aspx. I can confirm that this important work is included in the training of all GPs. Key to the learning are statements in the curriculum as follows:”

Source location

2017-0320-Response-by-RCGP
Page 2 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Examine safe prescribing and medicines management routinely in the Membership Examination.

Verbatim wording from the response

“RCGP curriculum currently contains safe prescribing and medicines management approaches and this is examined routinely as part of the Membership Examination which all doctors take should they wish to be accredited as a general practitioner. Details of the curriculum can be found at http://www.rcgp.org.uk/training-exams/gp-curriculum-overview/online-curriculum/managing-complex-care/3-14-drugs-and-alcohol-misuse.aspx. I can confirm that this important work is included in the training of all GPs. Key to the learning are statements in the curriculum as follows:”

Source location

2017-0320-Response-by-RCGP
Page 2 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Provide guidance on benzodiazepine and other medication use, including safe withdrawal support and the 2013 consensus statement.

Verbatim wording from the response

“The Royal College of General Practitioners provides guidance to general practitioners on the use of benzodiazepines and other medication. For your ease of reference, I have attached the 2013 consensus statement which was developed with a range of partner organisations.”

Source location

2017-0320-Response-by-RCGP
Page 2 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Support the RCGP certificate in the management of drug misuse.

Verbatim wording from the response

“In addition to my comments above, the RCGP supports a range of other educational initiatives which support the better prescribing of medication and thus the improved care of patients – these include the RCGP certificate in the management of drug misuse and also a free to access e learning programme.”

Source location

2017-0320-Response-by-RCGP
Page 2 · response
Published 3 December 2017

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Commenting on an individual GP’s performance is outside the College’s remit.

Verbatim wording from the response

“Similarly, it is not for us to comment on the performance of any individual GP and the information set out below is solely to show you what we provide in the context of training and advice to our Members.”

Source location

2017-0320-Response-by-RCGP
Page 1 · response
Published 3 December 2017

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
4/5

Data last updated 7 September 2026